News - Part 4

Laureate Pharma L.P. and TolerRx, Inc. Announce Second Antibody Manufacturing Services Agreement

PRINCETON, NJ – March 26, 2003 – Laureate Pharma L.P. and TolerRx, Inc. announce a second biopharmaceutical manufacturing and services agreement for TolerRx’s therapeutic monoclonal antibody pipeline. Under the contract, Laureate Pharma will provide purification and aseptic filling services to support TolerRx’s clinical trials. Terms of the agreement were not disclosed. “We are delighted to continue working with TolerRx. There is an excellent fit between TolerRx’s antibody therapeutics and Laureate’s…

Laureate Pharma L.P. Announces the Election of Lawrence W. Chakrin to its Board of Directors

Princeton, NJ – January 7, 2003 – Laureate Pharma L.P. today announced the appointment of Lawrence W. Chakrin, Ph.D. as a new member of its Board of Directors. Dr. Chakrin is Corporate Vice President of Science Applications International Corporation (SAIC), the largest employee-owned research and engineering firm in the United States, where he is responsible for corporate development of SAIC’s Biomedical Research Group. Before joining SAIC, Dr. Chakrin was a…

Stan Zeichner Named Director, Sales & Marketing at Laureate Pharma L.P.

Princeton, NJ – December 5, 2002 – Laureate Pharma L.P. announced the appointment of Stan Zeichner as Director, Sales & Marketing. Reporting to Robert J. Broeze, Ph.D., President, he is responsible for all aspects of sales and marketing for the company. “We are delighted to welcome Stan to our management team,” said Robert J. Broeze, Ph.D., President of Laureate Pharma L.P. “His more than 20 years experience in sales and…

John J. Morris Named Vice President, Controller & Strategic Planning at Laureate Pharma L.P.

Princeton, NJ – November 4, 2002 – Laureate Pharma L.P. announced the appointment of John J. Morris as Vice President, Controller & Strategic Planning. Reporting to Robert J. Broeze, Ph.D., President, he is responsible for all aspects of finance, supply chain management, information technology, and corporate planning. “It is my privilege to welcome John to our management team”, said Robert J. Broeze, Ph.D., President of Laureate Pharma L.P. “His impressive…

Laureate Pharma L.P. Announces the Election of F. Peter Boer to its Board of Directors

Princeton, NJ, October 17, 2002 /PRNewswire/ – Laureate Pharma L.P. today announced the appointment of F. Peter Boer, Ph.D. as a new member of its Board of Directors. Dr. Boer is President and CEO of Tiger Scientific Inc., a firm providing consulting and investment services in the technology arena. In addition, Dr. Boer is the John J. Lee Adjunct Professor at Yale University, where he teaches environmental engineering in the…

LAUREATE PHARMA L.P. AND SOUTHERN RESEARCH INSTITUTE ANNOUNCE DRUG DELIVERY AND COMMERCIAL MANUFACTURING STRATEGIC COLLABORATION AGREEMENT

PRINCETON, N.J. and BIRMINGHAM, Ala., Sept. 10, 2002 /PRNewswire/ — Laureate Pharma L.P. and Southern Research Institute announced today the initiation of a strategic collaboration agreement related to developing and manufacturing drug-delivery products using Southern Research’s proprietary microencapsulation process technologies. Under the agreement, Laureate Pharma and Southern Research will collaborate to provide pharmaceutical clients with full microencapsulation services that range from development through commercial scale manufacturing. Terms of the agreement…

LAUREATE PHARMA L.P. AND TOLERRX, INC. ANNOUNCE ANTIBODY MANUFACTURING SERVICES AGREEMENT.

PRINCETON, NJ – August 20, 2002 – Laureate Pharma L.P. and TolerRx, Inc. announce the initiation of a biopharmaceutical manufacturing and services agreement for TolerRx’s therapeutic monoclonal antibody pipeline. Under the contract, Laureate Pharma will provide purification and aseptic filling services to support TolerRx’s clinical trials. Terms of the agreement were not disclosed. “We believe there is an excellent fit between our expertise in development and manufacturing of biopharmaceuticals and…

Laureate Pharma and DrugAbuse Sciences Announce Commercial Manufacturing Services Agreement.

Princeton, NJ – June 24, 2002 – Laureate Pharma L.P. and DrugAbuse Sciences, Inc. announce the initiation of a contract manufacturing agreement related to a sustained release microsphere product. Under the agreement, Laureate Pharma will provide manufacturing services for DrugAbuse Sciences’ Naltrexone Depot product, currently in clinical trials. Terms of the agreement were not disclosed. “We are very excited about this agreement and look forward to building a long term…

Laureate Pharma Launches New Contract Manufacturing Venture

Company offers services for development and manufacture of biopharmaceuticals and sustained-release products Princeton, NJ – May 21, 2002 – Laureate Pharma Company announces the launch of contract manufacturing services at its two sites in New Jersey. Biopharmaceutical development and manufacturing services will be provided at a cGMP manufacturing facility in Princeton, NJ. Services related to sustained release microsphere products will be provided at its second manufacturing site in Totowa, NJ….